MGX (Metagenomi) Marketable Securities : $249.47 Mil (As of Sep. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Metagenomi Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Metagenomi's Marketable Securities for the quarter that ended in Sep. 2024 was $249.47 Mil.

Metagenomi's annual Marketable Securities increased from Dec. 2021 ($68.86 Mil) to Dec. 2022 ($177.69 Mil) but then declined from Dec. 2022 ($177.69 Mil) to Dec. 2023 ($130.58 Mil).

Metagenomi Marketable Securities Historical Data

The historical data trend for Metagenomi's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metagenomi Marketable Securities Chart

Metagenomi Annual Data

Trend

Dec21

Dec22

Dec23

Marketable Securities

68.86

177.69

130.58

Metagenomi Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Marketable Securities	Get a 7-Day Free Trial						191.03	130.58	224.85	238.74	249.47

Metagenomi Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Metagenomi (NAS:MGX) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Metagenomi Marketable Securities Related Terms

Thank you for viewing the detailed overview of Metagenomi's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Metagenomi Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Metagenomi Inc (NAS:MGX) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

5959 Horton Street, Emeryville, CA, USA, 94608

Website

https://www.metagenomi.co

Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).